Alpine Immune Sciences (ALPN) Tops Q1 EPS by 14c

Alpine Immune Sciences (NASDAQ: ALPN) reported Q1 EPS of ($0.28), $0.14 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $7.03 million versus the consensus estimate of $3.52 million.

For earnings history and earnings-related data on Alpine Immune Sciences (ALPN) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Kingsoft Cloud (KC) PT Raised to $21.40 at BofA Securities
• Ameramex International, Inc. (AMMX) Reports In-Line Q2 EPS